Evidence map›Paper›PMID 39861093›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression.

Sharif Karim Sayyed, Marzuqa Quraishi, D S Prabakaran, Balaji Chandrasekaran, Thiyagarajan Ramesh, Satish Kumar Rajasekharan, Chaitany Jayprakash Raorane, Tareeka Sonawane, Vinothkannan Ravichandran

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharif Karim SayyedAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai 410206, Maharashtra, India.ORCID 0009-0002-6520-4509
Marzuqa QuraishiAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai 410206, Maharashtra, India.ORCID 0000-0001-7784-6889
D S PrabakaranDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.ORCID 0000-0002-2486-5290
Balaji ChandrasekaranDepartment of Pharmaceutical Sciences, College of Pharmacy, Texas A&M University, College Station, TX 77845, USA.
Thiyagarajan RameshDepartment of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Satish Kumar RajasekharanDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.
Chaitany Jayprakash RaoraneSchool of Chemical Engineering, Yeungman University, Gyeongsan 38541, Republic of Korea.ORCID 0000-0001-6275-8042
Tareeka SonawaneAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai 410206, Maharashtra, India.
Vinothkannan RavichandranAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai 410206, Maharashtra, India.ORCID 0000-0002-8161-3620

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiretroviral drug developmentdrug resistancedual inhibitionHIV-1 integrase inhibitorsin vitro assaysmolecular docking simulation

Identifiers

PMID39861093
PMCPMC11768190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.